|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aligos Therapeutics (NASDAQ: ALGS) through any online brokerage.
There are no as such competitors for Aligos Therapeutics.
The latest price target for Aligos Therapeutics (NASDAQ: ALGS) was reported by Jefferies on November 10, 2020. The analyst firm set a price target for 26.00 expecting ALGS to rise to within 12 months (a possible 4.59% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $24.86 last updated Tue Jun 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aligos Therapeutics.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.